BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 15583332)

  • 21. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
    Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
    J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
    J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific antibodies against the nucleocapsid protein and S1 domain of spike glycoprotein in patients with severe acute respiratory syndrome].
    Mei YB; Wang YD; Liao ZY; Hao W; Che XY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):526-9. PubMed ID: 15949331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retraction for Woo et al., "False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-CoV Spike Polypeptide".
    Woo PCY; Lau SKP; Wong BHL; Chan KH; Hui WT; Kwan GSW; Peiris JSM; Couch RB; Yuen KY
    J Clin Microbiol; 2022 Nov; 60(11):e0144422. PubMed ID: 36314802
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
    Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
    Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development and application of a safe SARS-CoV neutralization assay based on lentiviral vectors pseudotyped with SARS-CoV spike protein].
    Yan KX; Tan WJ; Zhang XM; Wang HJ; Li Y; Ruan L
    Bing Du Xue Bao; 2007 Nov; 23(6):440-6. PubMed ID: 18092680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome.
    Guan M; Chen HY; Tan PH; Shen S; Goh PY; Tan YJ; Pang PH; Lu Y; Fong PY; Chin D
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1148-53. PubMed ID: 15539520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of non-pneumonic infections with SARS-correlated virus.
    Yip CW; Hon CC; Zeng F; Chow KY; Leung FC
    Lancet; 2004 May; 363(9423):1825; author reply 1826-7. PubMed ID: 15172784
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody detection of SARS-CoV spike and nucleocapsid protein.
    Chang MS; Lu YT; Ho ST; Wu CC; Wei TY; Chen CJ; Hsu YT; Chu PC; Chen CH; Chu JM; Jan YL; Hung CC; Fan CC; Yang YC
    Biochem Biophys Res Commun; 2004 Feb; 314(4):931-6. PubMed ID: 14751221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.
    Zhao J; Wang W; Wang W; Zhao Z; Zhang Y; Lv P; Ren F; Gao XM
    Clin Vaccine Immunol; 2007 Jul; 14(7):839-46. PubMed ID: 17475765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus.
    Chan CM; Tse H; Wong SS; Woo PC; Lau SK; Chen L; Zheng BJ; Huang JD; Yuen KY
    J Clin Virol; 2009 May; 45(1):54-60. PubMed ID: 19342289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot.
    Wang YD; Li Y; Xu GB; Dong XY; Yang XA; Feng ZR; Tian C; Chen WF
    Clin Immunol; 2004 Nov; 113(2):145-50. PubMed ID: 15451470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS.
    Saijo M; Ogino T; Taguchi F; Fukushi S; Mizutani T; Notomi T; Kanda H; Minekawa H; Matsuyama S; Long HT; Hanh NT; Kurane I; Tashiro M; Morikawa S
    J Virol Methods; 2005 May; 125(2):181-6. PubMed ID: 15794988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Chan KH; Tam VK; Peiris JS; Yuen KY
    J Clin Microbiol; 2004 May; 42(5):2306-9. PubMed ID: 15131220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular cloning and expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid protein and its clinical application].
    Lu J; Zhou BP; Zhou YS; Jiang XL; Wen LX; Le XH; Li B; Xu LM; Li LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):64-7. PubMed ID: 16201478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43.
    Kim J; Kim M; Kim D; Park S; Kang M; Baek K; Choi JK; Maharjan S; Akauliya M; Lee Y; Kwon HJ
    Front Immunol; 2022; 13():835333. PubMed ID: 35359936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS.
    Timani KA; Ye L; Ye L; Zhu Y; Wu Z; Gong Z
    J Clin Virol; 2004 Aug; 30(4):309-12. PubMed ID: 15163419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid.
    Leung DT; Tam FC; Ma CH; Chan PK; Cheung JL; Niu H; Tam JS; Lim PL
    J Infect Dis; 2004 Jul; 190(2):379-86. PubMed ID: 15216476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.